Literature DB >> 23845852

Co-evolution of sphingomyelin and the ceramide transport protein CERT.

Kentaro Hanada1.   

Abstract

Life creates many varieties of lipids. The choline-containing sphingophospholipid sphingomyelin (SM) exists ubiquitously or widely in vertebrates and lower animals, but is absent or rare in bacteria, fungi, protists, and plants. In the biosynthesis of SM, ceramide, which is synthesized in the endoplasmic reticulum, is transported to the Golgi region by the ceramide transport protein CERT, probably in a non-vesicular manner, and is then converted to SM by SM synthase, which catalyzes the reaction of phosphocholine transfer from phosphatidylcholine (PtdCho) to ceramide. Recent advances in genomics and lipidomics indicate that the phylogenetic occurrence of CERT and its orthologs is nearly parallel to that of SM. Based on the chemistry of lipids together with evolutionary aspects of SM and CERT, several concepts are here proposed. SM may serve as a chemically inert and robust, but non-covalently interactive lipid class at the outer leaflet of the plasma membrane. The functional domains and peptidic motifs of CERT are separated by exon units, suggesting an exon-shuffling mechanism for the generation of an ancestral CERT gene. CERT may have co-evolved with SM to bypass a competing metabolic reaction at the bifurcated point in the anabolism of ceramide. Human CERT is identical to the splicing variant of human Goodpasture antigen-binding protein (GPBP) annotated as an extracellular non-canonical serine/threonine protein kinase. The relationship between CERT and GPBP has also been discussed from an evolutionary aspect. Moreover, using an analogy of "compatible (or osmoprotective) solutes" that can accumulate to very high concentrations in the cytosol without denaturing proteins, choline phospholipids such as PtdCho and SM may act as compatible phospholipids in biomembranes. This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biology.
© 2013.

Entities:  

Keywords:  Choline; Compatible solute; Goodpasture antigen; Lipid transport; Membrane contact; Pleckstrin homology

Mesh:

Substances:

Year:  2013        PMID: 23845852     DOI: 10.1016/j.bbalip.2013.06.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Phosphoregulation of the ceramide transport protein CERT at serine 315 in the interaction with VAMP-associated protein (VAP) for inter-organelle trafficking of ceramide in mammalian cells.

Authors:  Keigo Kumagai; Miyuki Kawano-Kawada; Kentaro Hanada
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

2.  Phosphoinositide binding by the PH domain in ceramide transfer protein (CERT) is inhibited by hyperphosphorylation of an adjacent serine-repeat motif.

Authors:  Toshihiko Sugiki; Daichi Egawa; Keigo Kumagai; Chojiro Kojima; Toshimichi Fujiwara; Koh Takeuchi; Ichio Shimada; Kentaro Hanada; Hideo Takahashi
Journal:  J Biol Chem       Date:  2018-05-30       Impact factor: 5.157

Review 3.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

4.  StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis.

Authors:  Masanori Fukushima; Debanjali Dasgupta; Amy S Mauer; Eiji Kakazu; Kazuhiko Nakao; Harmeet Malhi
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

5.  2-Deoxy-D-glucose treatment changes the Golgi apparatus architecture without blocking synthesis of complex lipids.

Authors:  Carmen Ranftler; Claudia Meisslitzer-Ruppitsch; Herbert Stangl; Clemens Röhrl; Stefanie Fruhwürth; Josef Neumüller; Margit Pavelka; Adolf Ellinger
Journal:  Histochem Cell Biol       Date:  2014-11-25       Impact factor: 4.304

6.  Glucosylceramide Contained in Koji Mold-Cultured Cereal Confers Membrane and Flavor Modification and Stress Tolerance to Saccharomyces cerevisiae during Coculture Fermentation.

Authors:  Kazutaka Sawada; Tomoya Sato; Hiroshi Hamajima; Lahiru Niroshan Jayakody; Miyo Hirata; Mikako Yamashiro; Marie Tajima; Susumu Mitsutake; Koji Nagao; Keisuke Tsuge; Fumiyoshi Abe; Kentaro Hanada; Hiroshi Kitagaki
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

Review 7.  Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.

Authors:  Na Sun; Richard F Keep; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2016-06-24       Impact factor: 6.829

Review 8.  Sphingolipid metabolites in inflammatory disease.

Authors:  Michael Maceyka; Sarah Spiegel
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

9.  Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein.

Authors:  Carl Darris; Fernando Revert; Francisco Revert-Ros; Roberto Gozalbo-Rovira; Andrew Feigley; Aaron Fidler; Ernesto Lopez-Pascual; Juan Saus; Billy G Hudson
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

10.  Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs.

Authors:  Toshiyuki Yamaji; Kentaro Hanada
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.